Curanex Pharmaceuticals (CURX)

• Market cap: $9.11M
• 1 day: -4.75%
• 5 days: 2.56%
• 1 month: -1.95%
• 3 months: -16.58%
• 6 months: -29.33%
• Year to date: -12.84%
• 1 year: -92.01%
• 5 years: -92.01%
• 10 years: -92.01%
• Sector: Healthcare
• Industry: Biotechnology

About: Curanex Pharmaceuticals Inc is engaged in discovering, developing, and commercializing botanical drugs for treating unmet medical needs in patients with inflammatory disease. Its compound, Phyto-N, is in preclinical research for six indications: ulcerative colitis, atopic dermatitis, COVID-19, type 2 diabetes, nonalcoholic fatty liver disease (NAFLD) and gout. Phyto-N, is a proprietary botanical extract with chemical components and pharmacological activities that harnesses potential anti-inflammatory properties of a medicinal plant.

Employees: 6